GENinCode (LON:GENI) Stock Jumps 16.2% – Here’s What Happened

GENinCode Plc (LON:GENI)’s stock price traded up 16.2% during trading on Tuesday. The stock traded as high as GBX 0.70 and last traded at GBX 0.70. Approximately 3,865,641 shares traded hands during trading, a decline of 21% from the average session volume of 4,872,882 shares. The stock had previously closed at GBX 0.60.

GENinCode Trading Up 16.2%

The company has a quick ratio of 15.88, a current ratio of 2.22 and a debt-to-equity ratio of 4.75. The stock’s fifty day moving average price is GBX 0.84 and its two-hundred day moving average price is GBX 0.95. The company has a market capitalization of £5.25 million, a PE ratio of -0.55 and a beta of 0.59.

GENinCode (LON:GENI) last announced its quarterly earnings results on Tuesday, September 29th. The company reported GBX (0.38) earnings per share (EPS) for the quarter. GENinCode had a negative net margin of 202.42% and a negative return on equity of 481.34%. Sell-side analysts anticipate that GENinCode Plc will post -7.13 earnings per share for the current year.

About GENinCode

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.